I agree that this site is using cookies. You can find further informations here.
X
Maddocks, Kami J
214  results:
Search for persons X
?
1

Siltuximab Prophylaxis Prior to Standard of Care CD19 Direc..:

Voorhees, Timothy ; Huang, Ying ; Denlinger, Nathan...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S355-S356 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Safety of extended pirtobrutinib exposure in relapsed and/o..:

Roeker, Lindsey E. ; Coombs, Catherine C. ; Shah, Nirav N....
Acta Haematologica.  , 2024
Link: https://doi.org/10.1159/..
 
?
3

Does TRIANGLE take down transplantation in mantle cell lymp..:

Martin, Peter ; Maddocks, Kami
The Lancet.  403 (2024)  10441 - p. 2264-2265 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Acalabrutinib plus venetoclax and rituximab in treatment-na..:

Wang, Michael L ; Robak Prof., Tadeusz ; Maddocks, Kami J...
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
5

Brentuximab Vedotin Plus Ibrutinib in Relapsed and Refracto..:

Mei, Matthew ; Tsai, Ni-Chun ; Palmer, Joycelynne...
Clinical Lymphoma Myeloma and Leukemia.  , 2024
Link: https://doi.org/10.1016/..
 
?
6

Postinfusion PD-1+ CD8+ CAR T cells identify patients respo..:

Denlinger, Nathan ; Song, No-Joon ; Zhang, Xiaoli...
Blood Advances.  8 (2024)  12 - p. 3140-3153 , 2024
Link: https://doi.org/10.1182/..
 
?
7

Prognostic relevance of circulating lymphoma cells at diagn..:

Annunzio, Kaitlin ; Bhatta, Subodh ; Hanel, Walter...
Hematological Oncology.  42 (2024)  3 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
8

POSTER: ABCL-450 Five-Year Efficacy and Safety of Tafasitam..:

Duell, Johannes ; Abrisqueta, Pau ; Andre, Marc...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S206 , 2023
Link: https://doi.org/10.1016/..
 
?
9

POSTER: CT-166 Long-Term Safety With ≥12 Months of Pirtobru..:

Muehlenbein, Catherine E. ; Coombs, Catherine C. ; Shah, Nirav N....
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S229 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Clinical Treatment Guidelines for Tafasitamab plus Lenalido..:

Nedved, Adrienne ; Maddocks, Kami ; Nowakowski, Grzegorz S
The Oncologist.  28 (2023)  3 - p. 199-207 , 2023
Link: https://doi.org/10.1093/..
 
?
11

P618: LONG-TERM SAFETY WITH ≥12 MONTHS OF PIRTOBRUTINIB IN ..:

Jurczak, Wojciech ; Coombs, Catherine C. ; Shah, Nirav N....
HemaSphere.  7 (2023)  S3 - p. e6206253 , 2023
Link: https://doi.org/10.1097/..
 
?
12

CT-166 Long-Term Safety With ≥12 Months of Pirtobrutinib in..:

Muehlenbein, Catherine E. ; Coombs, Catherine C. ; Shah, Nirav N....
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S520 , 2023
Link: https://doi.org/10.1016/..
 
?
13

P1087: PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR PRE-TREATED ..:

Jurczak, Wojciech ; Luigi Zinzani, Pier ; Eyre, Toby A....
HemaSphere.  7 (2023)  S3 - p. e45636b5 , 2023
Link: https://doi.org/10.1097/..
 
?
14

POSTER: MCL-155 Pirtobrutinib in Covalent BTK Inhibitor Pre..:

Wang, Michael L. ; Shah, Nirav N. ; Jurczak, Wojciech...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S213 , 2023
Link: https://doi.org/10.1016/..
 
?
15

MCL-155 Pirtobrutinib in Covalent BTK Inhibitor Pre-Treated..:

Wang, Michael L. ; Shah, Nirav N. ; Jurczak, Wojciech...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S459 , 2023
Link: https://doi.org/10.1016/..
 
1-15